Literature DB >> 17251302

The ubiquitous cellular transcriptional factor USF targets the varicella-zoster virus open reading frame 10 promoter and determines virulence in human skin xenografts in SCIDhu mice in vivo.

Xibing Che1, Barbara Berarducci, Marvin Sommer, William T Ruyechan, Ann M Arvin.   

Abstract

Varicella-zoster virus (VZV) open reading frame 10 (ORF10) is a determinant of virulence in SCIDhu skin xenografts but not in human T cells in vivo. In this analysis of the regulation of ORF10 transcription, we have identified four ORF10-related transcripts, including a major 1.3-kb RNA spanning ORF10 only and three other read-through transcripts. Rapid-amplification-of-cDNA-ends experiments indicated that the 1.3-kb transcript of ORF10 has single initiation and termination sites. In transient expression assays, the ORF10 promoter was strongly stimulated by the major VZV transactivator, IE62. Deletion analyses revealed approximate boundaries for the full ORF10 promoter activity between -75 and -45 and between +5 and -8, relative to the ORF10 transcription start site. The recombinant virus POKA10-Deltapro, with the ORF10 promoter deletion, blocked transcription of ORF10 and also of ORF9A and ORF9 mRNAs, whereas expression of read-through ORF9A/9/10 and ORF9/10 transcripts was increased, compensating for the loss of the monocistronic mRNAs. The cellular factor USF bound specifically to its consensus site within the ORF10 promoter and was required for IE62 transactivation, whereas disrupting the predicted TATA boxes or Oct-1 binding elements had no effect. The USF binding site was disrupted in the recombinant virus, POKA10-proDeltaUSF, and no ORF10 protein was produced. Both ORF10 promoter mutants reduced VZV replication in SCIDhu skin xenografts. These observations provided further evidence of the contribution of the ORF10 protein to VZV pathogenesis in skin and demonstrated that VZV depends upon the cellular transcriptional factor USF to support its virulence in human skin in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17251302      PMCID: PMC1866059          DOI: 10.1128/JVI.02537-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA.

Authors:  R J Cohrs; M Barbour; D H Gilden
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

2.  Mutational analysis of the varicella-zoster virus ORF62/63 intergenic region.

Authors:  Jeremy O Jones; Marvin Sommer; Shaye Stamatis; Ann M Arvin
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

3.  Disruption of the varicella-zoster virus dUTPase and the adjacent ORF9A gene results in impaired growth and reduced syncytia formation in vitro.

Authors:  J Ross; M Williams; J I Cohen
Journal:  Virology       Date:  1997-08-04       Impact factor: 3.616

4.  Promoter activation by the varicella-zoster virus major transactivator IE62 and the cellular transcription factor USF.

Authors:  Min Yang; Hua Peng; John Hay; William T Ruyechan
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  Influence of different cellular transcription factors on the regulation of varicella-zoster virus glycoproteins E (gE) and I (gI) UTR's activity.

Authors:  M Rahaus; M H Wolff
Journal:  Virus Res       Date:  1999-07       Impact factor: 3.303

6.  Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo.

Authors:  Xibing Che; Leigh Zerboni; Marvin H Sommer; Ann M Arvin
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  Anatomy of the varicella-zoster virus open-reading frame 4 promoter.

Authors:  E J Michael; K M Kuck; P R Kinchington
Journal:  J Infect Dis       Date:  1998-11       Impact factor: 5.226

8.  Proteins and cis-acting elements associated with transactivation of the varicella-zoster virus (VZV) immediate-early gene 62 promoter by VZV open reading frame 10 protein.

Authors:  H Moriuchi; M Moriuchi; J I Cohen
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Pseudorabies virus and equine herpesvirus 1 share a nonessential gene which is absent in other herpesviruses and located adjacent to a highly conserved gene cluster.

Authors:  J Baumeister; B G Klupp; T C Mettenleiter
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

10.  Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse.

Authors:  J F Moffat; L Zerboni; P R Kinchington; C Grose; H Kaneshima; A M Arvin
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

View more
  12 in total

1.  Identification and functional characterization of the Varicella zoster virus ORF11 gene product.

Authors:  Xibing Che; Stefan L Oliver; Marvin H Sommer; Jaya Rajamani; Mike Reichelt; Ann M Arvin
Journal:  Virology       Date:  2011-01-26       Impact factor: 3.616

2.  Mutational analysis of varicella-zoster virus (VZV) immediate early protein (IE62) subdomains and their importance in viral replication.

Authors:  Mohamed I Khalil; Xibing Che; Phillip Sung; Marvin H Sommer; John Hay; Ann M Arvin
Journal:  Virology       Date:  2016-02-23       Impact factor: 3.616

3.  Cellular transcription factor YY1 mediates the varicella-zoster virus (VZV) IE62 transcriptional activation.

Authors:  Mohamed I Khalil; Marvin Sommer; Ann Arvin; John Hay; William T Ruyechan
Journal:  Virology       Date:  2013-12-12       Impact factor: 3.616

Review 4.  Varicella-zoster virus T cell tropism and the pathogenesis of skin infection.

Authors:  Ann M Arvin; Jennifer F Moffat; Marvin Sommer; Stefan Oliver; Xibing Che; Susan Vleck; Leigh Zerboni; Chia-Chi Ku
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

5.  Differential effects of Sp cellular transcription factors on viral promoter activation by varicella-zoster virus (VZV) IE62 protein.

Authors:  Mohamed I Khalil; William T Ruyechan; John Hay; Ann Arvin
Journal:  Virology       Date:  2015-07-23       Impact factor: 3.616

6.  Regulation of the varicella-zoster virus ORF3 promoter by cellular and viral factors.

Authors:  Mohamed I Khalil; Marvin Sommer; Ann Arvin; John Hay; William T Ruyechan
Journal:  Virology       Date:  2013-03-21       Impact factor: 3.616

7.  Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor.

Authors:  Zhen Zhang; Anca Selariu; Charles Warden; Grace Huang; Ying Huang; Oluleke Zaccheus; Tong Cheng; Ningshao Xia; Hua Zhu
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

8.  Regulation of the ORF61 promoter and ORF61 functions in varicella-zoster virus replication and pathogenesis.

Authors:  Li Wang; Marvin Sommer; Jaya Rajamani; Ann M Arvin
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

9.  Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I.

Authors:  Leigh Zerboni; Mike Reichelt; Carol D Jones; James L Zehnder; Hideki Ito; Ann M Arvin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-20       Impact factor: 11.205

10.  Cellular and viral factors regulate the varicella-zoster virus gE promoter during viral replication.

Authors:  Barbara Berarducci; Marvin Sommer; Leigh Zerboni; Jaya Rajamani; Ann M Arvin
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.